96 related articles for article (PubMed ID: 38459552)
1. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
Hofmeyr GJ; Singata-Madliki M; Batting J; Balakrishna Y; Morroni C
BMC Womens Health; 2024 Mar; 24(1):167. PubMed ID: 38459552
[TBL] [Abstract][Full Text] [Related]
2. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial.
Hofmeyr GJ; Singata-Madliki M; Batting J; Steyn P; Thomas KK; Issema R; Beesham I; Mbatsane E; Morrison C; Deese J; Smit J; Philip N; Palanee-Phillips T; Reddy K; Onono M; Mastro TD; Baeten JM;
PLoS One; 2024; 19(5):e0299802. PubMed ID: 38722832
[TBL] [Abstract][Full Text] [Related]
3. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Huijbregts RP; Michel KG; Hel Z
Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
[TBL] [Abstract][Full Text] [Related]
4. Steroidal contraceptives: effect on bone fractures in women.
Lopez LM; Grimes DA; Schulz KF; Curtis KM; Chen M
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006033. PubMed ID: 24960023
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
[TBL] [Abstract][Full Text] [Related]
6. Continuation and satisfaction of reversible contraception.
Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
[TBL] [Abstract][Full Text] [Related]
7. Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
Kaplan J; Turok DK; Gero A; Kaiser JE; Simmons RG; Fay KE
Contraception; 2023 Feb; 118():109893. PubMed ID: 36240903
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
Beasley A; White KO; Cremers S; Westhoff C
Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 Year.
Sanders JN; Higgins JA; Adkins DE; Stoddard GJ; Gawron LM; Turok DK
Womens Health Issues; 2018; 28(5):401-407. PubMed ID: 30131221
[TBL] [Abstract][Full Text] [Related]
10. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
[TBL] [Abstract][Full Text] [Related]
11. Acceptance, Adherence, and Side Effects of Depot Medroxyprogesterone Acetate: A Prospective Observational Study.
Rajaraman R; Vaithilingan S; Selvavinayagam TS
Cureus; 2024 Apr; 16(4):e58700. PubMed ID: 38779259
[TBL] [Abstract][Full Text] [Related]
12. Risk of Stroke in Women Using Levonorgestrel-Releasing Intrauterine Device for Contraception.
Letnar G; Andersen KK; Olsen TS
Stroke; 2024 Jul; 55(7):1830-1837. PubMed ID: 38753961
[TBL] [Abstract][Full Text] [Related]
13. Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial.
Nwaohiri AN; Tang JH; Stanczyk F; Chinula L; Hurst S; Davis NL; Tegha G; Haddad L; Kourtis AP
Contraception; 2018 Apr; 97(4):354-356. PubMed ID: 29246819
[TBL] [Abstract][Full Text] [Related]
14. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
Guthrie BL; Introini A; Roxby AC; Choi RY; Bosire R; Lohman-Payne B; Hirbod T; Farquhar C; Broliden K
J Acquir Immune Defic Syndr; 2015 May; 69(1):1-10. PubMed ID: 25622059
[TBL] [Abstract][Full Text] [Related]
15. Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives.
Caruso S; Caruso G; Iraci Sareri M; Di Guardo F; Incognito GG; Palumbo M
Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):103-108. PubMed ID: 38588444
[TBL] [Abstract][Full Text] [Related]
16. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.
Robinson JA; Jamshidi R; Burke AE
Infect Dis Obstet Gynecol; 2012; 2012():890160. PubMed ID: 22927715
[TBL] [Abstract][Full Text] [Related]
17. Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
Phung MT; Lee AW; Wu AH; Berchuck A; Cho KR; Cramer DW; Doherty JA; Goodman MT; Hanley GE; Harris HR; McLean K; Modugno F; Moysich KB; Mukherjee B; Schildkraut JM; Terry KL; Titus LJ; Jordan SJ; Webb PM; Pike MC; Pearce CL; ; ;
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):927-935. PubMed ID: 33619020
[TBL] [Abstract][Full Text] [Related]
18. Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
Higgins JA; Sanders JN; Palta M; Turok DK
Obstet Gynecol; 2016 Nov; 128(5):1143-1151. PubMed ID: 27741195
[TBL] [Abstract][Full Text] [Related]
19. Effect of depot medroxyprogesterone acetate on glucose tolerance in generalized lipodystrophy.
Yauger BJ; Gorden P; Park J; Cochran E; Stratton P
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):445-7. PubMed ID: 18669758
[TBL] [Abstract][Full Text] [Related]
20. Sexual function, quality of life, anxiety, and depression in women of reproductive age using hormonal, nonhormonal, and no contraceptive methods.
Déa CA; Moreira ECH; Zamboti CL
J Sex Med; 2024 Jun; ():. PubMed ID: 38842258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
